Lisa E. Hensley mainly focuses on Virology, Immunology, Ebola virus, Ebolavirus and Ebola vaccine. Lisa E. Hensley integrates Virology with Filoviridae in her study. Her work in the fields of Immunology, such as Immune system, Antibody, Tumor necrosis factor alpha and Interferon, overlaps with other areas such as Proinflammatory cytokine.
Her ZMapp, Ebola Hemorrhagic Fever, Marburg virus disease and Zaire ebolavirus study, which is part of a larger body of work in Ebola virus, is frequently linked to Mononegavirales, bridging the gap between disciplines. Her Ebolavirus research is multidisciplinary, incorporating perspectives in Transmission and DNA sequencing. Her biological study spans a wide range of topics, including Vector, Vesicular stomatitis virus and Vaccine efficacy.
Her primary areas of study are Virology, Ebola virus, Immunology, Virus and Disease. Her Virology study frequently involves adjacent topics like Pathogenesis. In the subject of general Ebola virus, her work in Ebola Hemorrhagic Fever and Zaire ebolavirus is often linked to Filoviridae and Mononegavirales, thereby combining diverse domains of study.
Immune system, Ebola vaccine, Vaccination, Marburgvirus and Viral load are among the areas of Immunology where the researcher is concentrating her efforts. Her Virus research is multidisciplinary, relying on both Genome, Orthopoxvirus and Monkeypox virus. Lisa E. Hensley interconnects Transmission and Monkeypox in the investigation of issues within Disease.
The scientist’s investigation covers issues in Ebola virus, Virology, Virus, Disease and Outbreak. Her Ebola virus research incorporates themes from Plaque reduction neutralization test, Pharmacology, Transcriptome and In situ hybridization. Her study connects Antibody and Virology.
In her study, Macrophage, Infectivity, BALB/c and Cell culture is strongly linked to Semen, which falls under the umbrella field of Virus. Her Disease research includes elements of Transmission and Psychological intervention. Her Outbreak study integrates concerns from other disciplines, such as Disease cluster, Medical emergency and Vaccination.
Her main research concerns Ebola virus, Virology, Virus, Pharmacology and Severe acute respiratory syndrome coronavirus 2. Her research in Ebola virus intersects with topics in CRISPR, Lassa virus and Hemorrhagic Fevers. Her research on Virology frequently connects to adjacent areas such as Disease.
Antibody, Plaque reduction neutralization test, Neutralization and Serology is closely connected to Outbreak in her research, which is encompassed under the umbrella topic of Virus. Her work in the fields of Drug overlaps with other areas such as Bepridil, Angina, Chemistry and Toremifene Citrate. Lisa E. Hensley focuses mostly in the field of Severe acute respiratory syndrome coronavirus 2, narrowing it down to matters related to 2019-20 coronavirus outbreak and, in some cases, Computational biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S;Dodd Le;Davey Rt;Tshiani Mbaya O.
The New England Journal of Medicine (2019)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert.
Nature Medicine (2005)
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
Marceline Côté;John Misasi;John Misasi;Tao Ren;Anna Bruchez.
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
Thomas W. Geisbert;Lisa E. Hensley;Tom Larsen;Howard A. Young.
American Journal of Pathology (2003)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall;Christopher M. Coleman;Brit J. Hart;Thiagarajan Venkataraman.
Antimicrobial Agents and Chemotherapy (2014)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Thomas W. Geisbert;Amy Ch Lee;Marjorie Robbins;Joan B. Geisbert.
The Lancet (2010)
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
Thomas W Geisbert;Lisa E Hensley;Peter B Jahrling;Tom Larsen.
The Lancet (2003)
Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
Abdulaziz N. Alagaili;Thomas Briese;Nischay Mishra;Vishal Kapoor.
Molecular Evidence of Sexual Transmission of Ebola Virus
Suzanne E Mate;Jeffrey R Kugelman;Tolbert G Nyenswah;Jason T Ladner.
The New England Journal of Medicine (2015)
Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event
Thomas W. Geisbert;Howard A. Young;Peter B. Jahrling;Kelly J. Davis.
The Journal of Infectious Diseases (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: